Does the media refer more to RPID or PRE?

In the previous week, Rapid Micro Biosystems had 1 more articles in the media than Prenetics Global. MarketBeat recorded 2 mentions for Rapid Micro Biosystems and 1 mentions for Prenetics Global. Rapid Micro Biosystems' average media sentiment score of 0.00 equaled Prenetics Global'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Rapid Micro Biosystems 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Prenetics Global 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to RPID or LAB?

In the previous week, Standard BioTools had 1 more articles in the media than Rapid Micro Biosystems. MarketBeat recorded 3 mentions for Standard BioTools and 2 mentions for Rapid Micro Biosystems. Standard BioTools' average media sentiment score of 0.62 beat Rapid Micro Biosystems' score of 0.00 indicating that Standard BioTools is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Rapid Micro Biosystems 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Standard BioTools 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate OPTX or RPID?

Rapid Micro Biosystems has a consensus price target of $6.00, indicating a potential upside of 181.69%. Given Rapid Micro Biosystems' stronger consensus rating and higher possible upside, analysts clearly believe Rapid Micro Biosystems is more favorable than Syntec Optics. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Syntec Optics 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Rapid Micro Biosystems 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33

Does the media favor OPTX or RPID?

In the previous week, Syntec Optics and Syntec Optics both had 2 articles in the media. Syntec Optics' average media sentiment score of 0.64 beat Rapid Micro Biosystems' score of 0.00 indicating that Syntec Optics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Syntec Optics 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Rapid Micro Biosystems 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to RPID or MASS?

In the previous week, 908 Devices had 5 more articles in the media than Rapid Micro Biosystems. MarketBeat recorded 7 mentions for 908 Devices and 2 mentions for Rapid Micro Biosystems. 908 Devices' average media sentiment score of 0.73 beat Rapid Micro Biosystems' score of 0.00 indicating that 908 Devices is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Rapid Micro Biosystems 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral 908 Devices 1 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to RPID or NAUT?

In the previous week, Nautilus Biotechnology had 5 more articles in the media than Rapid Micro Biosystems. MarketBeat recorded 7 mentions for Nautilus Biotechnology and 2 mentions for Rapid Micro Biosystems. Nautilus Biotechnology's average media sentiment score of 1.06 beat Rapid Micro Biosystems' score of 0.00 indicating that Nautilus Biotechnology is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Rapid Micro Biosystems 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Nautilus Biotechnology 3 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Rapid Micro Biosystems (RPID) Competitors

$2.13 0.00 (0.00%)

Closing price 07/31/2026 04:00 PM Eastern

Extended Trading

$2.16 +0.03 (+1.36%)

As of 07/31/2026 06:03 PM Eastern

Compare

RPID vs. PRE, LAB, OPTX, MASS, and NAUT

Should you buy Rapid Micro Biosystems stock or one of its competitors? MarketBeat compares Rapid Micro Biosystems with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Rapid Micro Biosystems include Prenetics Global (PRE), Standard BioTools (LAB), Syntec Optics (OPTX), 908 Devices (MASS), and Nautilus Biotechnology (NAUT).

How does Rapid Micro Biosystems compare to Prenetics Global?

Rapid Micro Biosystems (NASDAQ:RPID) and Prenetics Global (NASDAQ:PRE) are related small-cap companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, dividends, analyst recommendations, earnings, risk, profitability and valuation.

Prenetics Global has higher revenue and earnings than Rapid Micro Biosystems. Prenetics Global is trading at a lower price-to-earnings ratio than Rapid Micro Biosystems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Rapid Micro Biosystems	$33.59M	2.93	-$47.12M	-$1.12	N/A
Prenetics Global	$92.39M	3.40	-$37.71M	-$4.58	N/A

Prenetics Global has a net margin of -62.45% compared to Rapid Micro Biosystems' net margin of -145.81%. Prenetics Global's return on equity of -20.33% beat Rapid Micro Biosystems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Rapid Micro Biosystems	-145.81%	-131.52%	-67.48%
Prenetics Global	-62.45%	-20.33%	-15.42%

Rapid Micro Biosystems has a beta of 1.44, indicating that its share price is 44% more volatile than the broader market. Comparatively, Prenetics Global has a beta of 0.26, indicating that its share price is 74% less volatile than the broader market.

Rapid Micro Biosystems presently has a consensus price target of $6.00, indicating a potential upside of 181.69%. Prenetics Global has a consensus price target of $34.25, indicating a potential upside of 83.74%. Given Rapid Micro Biosystems' higher probable upside, equities research analysts clearly believe Rapid Micro Biosystems is more favorable than Prenetics Global.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Rapid Micro Biosystems	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Prenetics Global	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60

In the previous week, Rapid Micro Biosystems had 1 more articles in the media than Prenetics Global. MarketBeat recorded 2 mentions for Rapid Micro Biosystems and 1 mentions for Prenetics Global. Rapid Micro Biosystems' average media sentiment score of 0.00 equaled Prenetics Global'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Rapid Micro Biosystems	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Prenetics Global	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

52.6% of Rapid Micro Biosystems shares are owned by institutional investors. Comparatively, 25.0% of Prenetics Global shares are owned by institutional investors. 12.7% of Rapid Micro Biosystems shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Prenetics Global beats Rapid Micro Biosystems on 8 of the 15 factors compared between the two stocks.

How does Rapid Micro Biosystems compare to Standard BioTools?

Rapid Micro Biosystems (NASDAQ:RPID) and Standard BioTools (NASDAQ:LAB) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, media sentiment, dividends, profitability, valuation and risk.

Rapid Micro Biosystems has higher earnings, but lower revenue than Standard BioTools. Rapid Micro Biosystems is trading at a lower price-to-earnings ratio than Standard BioTools, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Rapid Micro Biosystems	$33.59M	2.93	-$47.12M	-$1.12	N/A
Standard BioTools	$85.33M	3.97	-$74.90M	$0.20	4.34

Rapid Micro Biosystems currently has a consensus target price of $6.00, indicating a potential upside of 181.69%. Standard BioTools has a consensus target price of $1.35, indicating a potential upside of 55.53%. Given Rapid Micro Biosystems' stronger consensus rating and higher possible upside, equities analysts plainly believe Rapid Micro Biosystems is more favorable than Standard BioTools.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Rapid Micro Biosystems	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Standard BioTools	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67

Standard BioTools has a net margin of 73.46% compared to Rapid Micro Biosystems' net margin of -145.81%. Standard BioTools' return on equity of -8.18% beat Rapid Micro Biosystems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Rapid Micro Biosystems	-145.81%	-131.52%	-67.48%
Standard BioTools	73.46%	-8.18%	-6.43%

52.6% of Rapid Micro Biosystems shares are held by institutional investors. Comparatively, 53.7% of Standard BioTools shares are held by institutional investors. 12.7% of Rapid Micro Biosystems shares are held by insiders. Comparatively, 26.8% of Standard BioTools shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, Standard BioTools had 1 more articles in the media than Rapid Micro Biosystems. MarketBeat recorded 3 mentions for Standard BioTools and 2 mentions for Rapid Micro Biosystems. Standard BioTools' average media sentiment score of 0.62 beat Rapid Micro Biosystems' score of 0.00 indicating that Standard BioTools is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Rapid Micro Biosystems	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Standard BioTools	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Rapid Micro Biosystems has a beta of 1.44, suggesting that its stock price is 44% more volatile than the broader market. Comparatively, Standard BioTools has a beta of 1.39, suggesting that its stock price is 39% more volatile than the broader market.

Summary

Standard BioTools beats Rapid Micro Biosystems on 11 of the 16 factors compared between the two stocks.

How does Rapid Micro Biosystems compare to Syntec Optics?

Syntec Optics (NASDAQ:OPTX) and Rapid Micro Biosystems (NASDAQ:RPID) are related small-cap companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, media sentiment, risk, institutional ownership, profitability and analyst recommendations.

Syntec Optics has a net margin of -10.95% compared to Rapid Micro Biosystems' net margin of -145.81%. Syntec Optics' return on equity of -30.86% beat Rapid Micro Biosystems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Syntec Optics	-10.95%	-30.86%	-12.35%
Rapid Micro Biosystems	-145.81%	-131.52%	-67.48%

Syntec Optics has a beta of -0.8, suggesting that its stock price is 180% less volatile than the broader market. Comparatively, Rapid Micro Biosystems has a beta of 1.44, suggesting that its stock price is 44% more volatile than the broader market.

Rapid Micro Biosystems has a consensus price target of $6.00, indicating a potential upside of 181.69%. Given Rapid Micro Biosystems' stronger consensus rating and higher possible upside, analysts clearly believe Rapid Micro Biosystems is more favorable than Syntec Optics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Syntec Optics	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Rapid Micro Biosystems	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Syntec Optics has higher earnings, but lower revenue than Rapid Micro Biosystems. Syntec Optics is trading at a lower price-to-earnings ratio than Rapid Micro Biosystems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Syntec Optics	$28.08M	9.37	-$1.79M	-$0.08	N/A
Rapid Micro Biosystems	$33.59M	2.93	-$47.12M	-$1.12	N/A

52.6% of Rapid Micro Biosystems shares are owned by institutional investors. 0.8% of Syntec Optics shares are owned by insiders. Comparatively, 12.7% of Rapid Micro Biosystems shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Syntec Optics and Syntec Optics both had 2 articles in the media. Syntec Optics' average media sentiment score of 0.64 beat Rapid Micro Biosystems' score of 0.00 indicating that Syntec Optics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Syntec Optics	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Rapid Micro Biosystems	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Rapid Micro Biosystems beats Syntec Optics on 8 of the 15 factors compared between the two stocks.

How does Rapid Micro Biosystems compare to 908 Devices?

Rapid Micro Biosystems (NASDAQ:RPID) and 908 Devices (NASDAQ:MASS) are related small-cap companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, media sentiment, risk, dividends, profitability, analyst recommendations, institutional ownership and valuation.

Rapid Micro Biosystems has a beta of 1.44, indicating that its share price is 44% more volatile than the broader market. Comparatively, 908 Devices has a beta of 0.66, indicating that its share price is 34% less volatile than the broader market.

908 Devices has a net margin of -62.40% compared to Rapid Micro Biosystems' net margin of -145.81%. 908 Devices' return on equity of -14.03% beat Rapid Micro Biosystems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Rapid Micro Biosystems	-145.81%	-131.52%	-67.48%
908 Devices	-62.40%	-14.03%	-10.40%

52.6% of Rapid Micro Biosystems shares are owned by institutional investors. Comparatively, 88.1% of 908 Devices shares are owned by institutional investors. 12.7% of Rapid Micro Biosystems shares are owned by company insiders. Comparatively, 28.2% of 908 Devices shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

908 Devices has higher revenue and earnings than Rapid Micro Biosystems. 908 Devices is trading at a lower price-to-earnings ratio than Rapid Micro Biosystems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Rapid Micro Biosystems	$33.59M	2.93	-$47.12M	-$1.12	N/A
908 Devices	$56.20M	5.39	$19.49M	-$1.00	N/A

In the previous week, 908 Devices had 5 more articles in the media than Rapid Micro Biosystems. MarketBeat recorded 7 mentions for 908 Devices and 2 mentions for Rapid Micro Biosystems. 908 Devices' average media sentiment score of 0.73 beat Rapid Micro Biosystems' score of 0.00 indicating that 908 Devices is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Rapid Micro Biosystems	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
908 Devices	1 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Rapid Micro Biosystems currently has a consensus target price of $6.00, indicating a potential upside of 181.69%. 908 Devices has a consensus target price of $11.50, indicating a potential upside of 43.57%. Given Rapid Micro Biosystems' higher probable upside, research analysts clearly believe Rapid Micro Biosystems is more favorable than 908 Devices.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Rapid Micro Biosystems	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
908 Devices	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Summary

908 Devices beats Rapid Micro Biosystems on 11 of the 14 factors compared between the two stocks.

How does Rapid Micro Biosystems compare to Nautilus Biotechnology?

Rapid Micro Biosystems (NASDAQ:RPID) and Nautilus Biotechnology (NASDAQ:NAUT) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, valuation, institutional ownership, earnings, profitability and risk.

In the previous week, Nautilus Biotechnology had 5 more articles in the media than Rapid Micro Biosystems. MarketBeat recorded 7 mentions for Nautilus Biotechnology and 2 mentions for Rapid Micro Biosystems. Nautilus Biotechnology's average media sentiment score of 1.06 beat Rapid Micro Biosystems' score of 0.00 indicating that Nautilus Biotechnology is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Rapid Micro Biosystems	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Nautilus Biotechnology	3 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Rapid Micro Biosystems currently has a consensus target price of $6.00, indicating a potential upside of 181.69%. Nautilus Biotechnology has a consensus target price of $4.00, indicating a potential upside of 309.42%. Given Nautilus Biotechnology's higher possible upside, analysts plainly believe Nautilus Biotechnology is more favorable than Rapid Micro Biosystems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Rapid Micro Biosystems	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Nautilus Biotechnology	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Rapid Micro Biosystems has higher revenue and earnings than Nautilus Biotechnology. Nautilus Biotechnology is trading at a lower price-to-earnings ratio than Rapid Micro Biosystems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Rapid Micro Biosystems	$33.59M	2.93	-$47.12M	-$1.12	N/A
Nautilus Biotechnology	N/A	N/A	-$59M	-$0.45	N/A

Nautilus Biotechnology has a net margin of 0.00% compared to Rapid Micro Biosystems' net margin of -145.81%. Nautilus Biotechnology's return on equity of -37.58% beat Rapid Micro Biosystems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Rapid Micro Biosystems	-145.81%	-131.52%	-67.48%
Nautilus Biotechnology	N/A	-37.58%	-30.83%

Rapid Micro Biosystems has a beta of 1.44, suggesting that its share price is 44% more volatile than the broader market. Comparatively, Nautilus Biotechnology has a beta of 0.87, suggesting that its share price is 13% less volatile than the broader market.

52.6% of Rapid Micro Biosystems shares are held by institutional investors. Comparatively, 50.7% of Nautilus Biotechnology shares are held by institutional investors. 12.7% of Rapid Micro Biosystems shares are held by insiders. Comparatively, 41.1% of Nautilus Biotechnology shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Nautilus Biotechnology beats Rapid Micro Biosystems on 8 of the 15 factors compared between the two stocks.

Get Rapid Micro Biosystems News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RPID and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

RPID vs. The Competition

Export

Metric	Rapid Micro Biosystems	Life Sciences Tools & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$98.34M	$9.08B	$6.86B	$12.42B
Dividend Yield	N/A	1.47%	2.59%	10.03%
P/E Ratio	-1.90	58.47	282.27	24.66
Price / Sales	2.93	102.60	581.52	86.64
Price / Cash	N/A	25.63	28.60	46.71
Price / Book	2.84	5.05	10.93	6.07
Net Income	-$47.12M	$57.47B	$3.49B	$347.99M
7 Day Performance	5.97%	-0.09%	-0.64%	-0.42%
1 Month Performance	23.84%	-4.40%	-3.78%	-4.80%
1 Year Performance	-35.65%	14.98%	61.99%	18.61%

Rapid Micro Biosystems Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
RPID Rapid Micro Biosystems	2.1097 of 5 stars	$2.13 flat	$6.00 +181.7%	-35.6%	$98.34M	$33.59M	N/A	200
PRE Prenetics Global	1.5886 of 5 stars	$18.26 -3.5%	$34.25 +87.6%	+133.0%	$319.43M	$92.39M	N/A	1	Gap Up
LAB Standard BioTools	3.5701 of 5 stars	$0.79 +2.6%	$1.35 +69.9%	-33.2%	$302.38M	$85.33M	3.97	620	Upcoming Earnings Short Interest Decrease
OPTX Syntec Optics	0.2989 of 5 stars	$6.38 -10.6%	N/A	+281.9%	$287.60M	$28.08M	N/A	3	High Trading Volume
MASS 908 Devices	2.2249 of 5 stars	$7.03 -1.4%	$12.00 +70.7%	+24.8%	$269.61M	$56.20M	N/A	60	Positive News Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:RPID) was last updated on 8/3/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rapid Micro Biosystems (RPID) Competitors

RPID vs. PRE, LAB, OPTX, MASS, and NAUT

How does Rapid Micro Biosystems compare to Prenetics Global?

Summary

How does Rapid Micro Biosystems compare to Standard BioTools?

Summary

How does Rapid Micro Biosystems compare to Syntec Optics?

Summary

How does Rapid Micro Biosystems compare to 908 Devices?

Summary

How does Rapid Micro Biosystems compare to Nautilus Biotechnology?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RPID vs. The Competition

Rapid Micro Biosystems Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Rapid Micro Biosystems (RPID) Competitors

RPID vs. PRE, LAB, OPTX, MASS, and NAUT

How does Rapid Micro Biosystems compare to Prenetics Global?

Which has preferable valuation & earnings, RPID or PRE?

Is RPID or PRE more profitable?

Which has more volatility and risk, RPID or PRE?

Do analysts prefer RPID or PRE?

Does the media refer more to RPID or PRE?

Do insiders & institutionals have more ownership in RPID or PRE?

Summary

How does Rapid Micro Biosystems compare to Standard BioTools?

Which has stronger earnings & valuation, RPID or LAB?

Do analysts recommend RPID or LAB?

Is RPID or LAB more profitable?

Do insiders & institutionals believe in RPID or LAB?

Does the media refer more to RPID or LAB?

Which has more risk & volatility, RPID or LAB?

Summary

How does Rapid Micro Biosystems compare to Syntec Optics?

Is OPTX or RPID more profitable?

Which has more risk & volatility, OPTX or RPID?

Do analysts rate OPTX or RPID?

Which has higher earnings and valuation, OPTX or RPID?

Do institutionals & insiders hold more shares of OPTX or RPID?

Does the media favor OPTX or RPID?

Summary

How does Rapid Micro Biosystems compare to 908 Devices?

Which has more volatility & risk, RPID or MASS?

Is RPID or MASS more profitable?

Do insiders & institutionals hold more shares of RPID or MASS?

Which has higher earnings & valuation, RPID or MASS?

Does the media refer more to RPID or MASS?

Do analysts rate RPID or MASS?

Summary

How does Rapid Micro Biosystems compare to Nautilus Biotechnology?

Does the media refer more to RPID or NAUT?

Do analysts prefer RPID or NAUT?

Which has higher valuation and earnings, RPID or NAUT?

Is RPID or NAUT more profitable?

Which has more risk & volatility, RPID or NAUT?

Do insiders and institutionals hold more shares of RPID or NAUT?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RPID vs. The Competition

Rapid Micro Biosystems Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools